Abraxane for Injectable Suspension 100mg

Manufacturer
BAXTER ONCOLOGY GMBH(GERMANY)

Registraction Number
MAL14125061ACRZ

Content:
Abraxane for Injectable Suspension 100mg contains 100 mg of paclitaxel protein-bound particles (albumin-bound) per vial. Paclitaxel is a chemotherapy drug that works by interfering with the growth of cancer cells.
Indications:

• Metastatic Breast Cancer: Treatment of breast cancer that has spread to other parts of the body, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.
• Non-Small Cell Lung Cancer (NSCLC): As first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
• Metastatic Adenocarcinoma of the Pancreas: As first-line treatment in combination with gemcitabine.

1. Administration: Administer intravenously (IV) over 30 minutes.
2. Dosage: Follow your doctor's prescription. The dosage may vary based on the patient's condition and response to treatment.
3. Monitoring: Regular monitoring of blood cell counts and other parameters is essential.
4. Precautions: Avoid use in patients with severe neutropenia, liver impairment, or those who have had severe allergic reactions to paclitaxel.